Topic Editors
Advancing Molecular and Regenerative Therapies for Corneal and Retinal Disorders
Topic Information
Dear Colleagues,
Corneal and retinal diseases remain leading causes of visual impairment and blindness worldwide, profoundly affecting patients’ quality of life. Although conventional pharmacological, surgical, and device-based treatments have improved clinical outcomes, many degenerative, inflammatory, hereditary, and ischemic ocular disorders still lack effective disease-modifying therapies. Recent advances in molecular biology, stem cell science, tissue engineering, gene editing, drug delivery systems, and ocular imaging have opened new avenues for restoring ocular structure and function.
This Topic aims to highlight emerging molecular and regenerative approaches for corneal and retinal diseases. We welcome original research articles, reviews, and translational studies focusing on mechanisms of disease, novel therapeutic targets, cell-based therapies, gene and RNA-based interventions, extracellular vesicles, biomaterials, organoids, and advanced drug delivery platforms. Studies integrating molecular insights with clinical phenotypes, imaging biomarkers, or therapeutic outcomes are particularly encouraged.
By bringing together basic, translational, and clinical research, this Topic seeks to promote a deeper understanding of ocular disease pathogenesis and to accelerate the development of innovative therapies for vision preservation and restoration.
Dr. Ryoji Yanai
Prof. Dr. Ryo Mukai
Dr. Koji Kitazawa
Topic Editors
Keywords
- corneal diseases
- retinal diseases
- molecular therapy
- regenerative medicine
- stem cell therapy
- gene therapy
- drug delivery
- ocular inflammation
- tissue engineering
- vision restoration
Participating Journals
| Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC | |
|---|---|---|---|---|---|---|
Cells
|
6.0 | 11.4 | 2012 | 14.9 Days | CHF 2700 | Submit |
International Journal of Molecular Sciences
|
5.6 | 10.0 | 2000 | 17.5 Days | CHF 2900 | Submit |
Journal of Clinical Medicine
|
3.3 | 5.2 | 2012 | 16.6 Days | CHF 2600 | Submit |
Vision
|
2.7 | 3.5 | 2017 | 21.1 Days | CHF 1800 | Submit |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.
